75 related articles for article (PubMed ID: 2544646)
1. Cholera toxin as a mucosal adjuvant. Glutaraldehyde treatment dissociates adjuvanticity from toxicity.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1989 Jul; 143(2):484-90. PubMed ID: 2544646
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
3. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
4. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased.
Nedrud JG; Sigmund N
Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580
[TBL] [Abstract][Full Text] [Related]
5. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
Lycke NY
J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421
[TBL] [Abstract][Full Text] [Related]
6. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
7. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice.
Liang XP; Lamm ME; Nedrud JG
Reg Immunol; 1989; 2(4):244-8. PubMed ID: 2561961
[TBL] [Abstract][Full Text] [Related]
8. Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin.
Navarro-García F; Pedroso M; López-Revilla R
Clin Immunol; 2000 Nov; 97(2):182-8. PubMed ID: 11027459
[TBL] [Abstract][Full Text] [Related]
9. Cholera toxin promotes B cell isotype differentiation.
Lycke N; Strober W
J Immunol; 1989 Jun; 142(11):3781-7. PubMed ID: 2785565
[TBL] [Abstract][Full Text] [Related]
10. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.
Lycke N; Erlandsson L; Ekman L; Schön K; Leanderson T
J Immunol; 1999 Jul; 163(2):913-9. PubMed ID: 10395687
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit.
Elson CO; Holland SP; Dertzbaugh MT; Cuff CF; Anderson AO
J Immunol; 1995 Feb; 154(3):1032-40. PubMed ID: 7822780
[TBL] [Abstract][Full Text] [Related]
12. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
[TBL] [Abstract][Full Text] [Related]
13. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo.
Lycke N; Bromander AK; Ekman L; Karlsson U; Holmgren J
J Immunol; 1989 Jan; 142(1):20-7. PubMed ID: 2783324
[TBL] [Abstract][Full Text] [Related]
14. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.
Vajdy M; Lycke NY
Immunology; 1992 Mar; 75(3):488-92. PubMed ID: 1572696
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.
Agren LC; Ekman L; Löwenadler B; Lycke NY
J Immunol; 1997 Apr; 158(8):3936-46. PubMed ID: 9103464
[TBL] [Abstract][Full Text] [Related]
16. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.
Agren LC; Ekman L; Löwenadler B; Nedrud JG; Lycke NY
J Immunol; 1999 Feb; 162(4):2432-40. PubMed ID: 9973526
[TBL] [Abstract][Full Text] [Related]
17. Selective induction of mucosal immune responses to 2-acetylaminofluorene.
Silbart LK; McAleer F; Rasmussen MV; Goslinoski L; Keren DF; Finley A; Van Kruiningen HJ; Winchell JM
Anticancer Res; 1996; 16(2):651-60. PubMed ID: 8687111
[TBL] [Abstract][Full Text] [Related]
18. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin.
Wilson AD; Clarke CJ; Stokes CR
Scand J Immunol; 1990 Apr; 31(4):443-51. PubMed ID: 2333468
[TBL] [Abstract][Full Text] [Related]
19. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1.
Kim PH; Eckmann L; Lee WJ; Han W; Kagnoff MF
J Immunol; 1998 Feb; 160(3):1198-203. PubMed ID: 9570534
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategy.
Yoshino N; Fujihashi K; Hagiwara Y; Kanno H; Takahashi K; Kobayashi R; Inaba N; Noda M; Sato S
Vaccine; 2009 Jul; 27(35):4808-17. PubMed ID: 19539583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
